Josu de la Fuente, Donatella Baronciani, Mathilde Fekom, Arnaud Dalissier, Marco Zecca, Franco Locatelli, Giorgio La Nasa, Raffaella Cerretti, Tariq Ghafoor, Giuseppe Visani, Hakan Ozdogu, Fabio Ciceri, Ashrafsadat Mousavi, Sandrine Bremathas, Selim Corbacioglu, Emanuele Angelucci. "The need for a subsequent HCT is a late & continuous risk and with significant impact in overall survival in haemoaglobinopathies: Real-world data from 2000–2022. an analysis of the european society for blood and marrow transplantation (EBMT) hemoglobinopathy working party.." Blood, 2025. doi:10.1182/blood-2025-178